Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.2 GBP
211.58 M GBP
4.46 B GBP
844.38 M
About SMITH & NEPHEW PLC ORD USD0.20
Sector
Industry
CEO
Deepak S Nath
Website
Headquarters
Watford
Founded
1856
ISIN
GB0009223206
FIGI
BBG000BF2206
Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.
S&N Long.New CFO and medical shares becoming attractive?
Idea only. Don't trade based on my ramblings.
Only risk 1R on any trade.
SNN, Smith & Nephew ADR - Trailing Stop after a breakoutNYSE:SNN
This level had resisted six times.
At the breakout the sellers were clearly few at that point and this was really a must for my strategies.
Let's follow the trend in trailing stop.
SN. Trend continuation?Seems like the pullback is nearly finishing and a beautiful triangle is forming.
Smith and Nephew potential If short term trend line and 1445 can hold good potential bullish If not longer term Trend line could offer good R/R
Medical Tech Mar17With Intuitive, Stryker all up at all time highs i'm hunting for medical robotics companies to acquire.
Smith & Nephew looking for a move below 29 to get long
seekingalpha.com
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SN. is 986.0 GBX — it has increased by 0.94% in the past 24 hours. Watch SMITH & NEPHEW PLC ORD USD0.20 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange SMITH & NEPHEW PLC ORD USD0.20 stocks are traded under the ticker SN..
SN. stock has risen by 0.28% compared to the previous week, the month change is a 0.63% rise, over the last year SMITH & NEPHEW PLC ORD USD0.20 has showed a −7.42% decrease.
We've gathered analysts' opinions on SMITH & NEPHEW PLC ORD USD0.20 future price: according to them, SN. price has a max estimate of 1,490.05 GBX and a min estimate of 1,032.94 GBX. Watch SN. chart and read a more detailed SMITH & NEPHEW PLC ORD USD0.20 stock forecast: see what analysts think of SMITH & NEPHEW PLC ORD USD0.20 and suggest that you do with its stocks.
SN. stock is 2.49% volatile and has beta coefficient of 0.70. Track SMITH & NEPHEW PLC ORD USD0.20 stock price on the chart and check out the list of the most volatile stocks — is SMITH & NEPHEW PLC ORD USD0.20 there?
Today SMITH & NEPHEW PLC ORD USD0.20 has the market capitalization of 8.60 B, it has decreased by −0.35% over the last week.
Yes, you can track SMITH & NEPHEW PLC ORD USD0.20 financials in yearly and quarterly reports right on TradingView.
SMITH & NEPHEW PLC ORD USD0.20 is going to release the next earnings report on Feb 25, 2025. Keep track of upcoming events with our Earnings Calendar.
SN. earnings for the last half-year are 0.30 GBX per share, whereas the estimation was 0.31 GBX, resulting in a −4.28% surprise. The estimated earnings for the next half-year are 0.37 GBX per share. See more details about SMITH & NEPHEW PLC ORD USD0.20 earnings.
SMITH & NEPHEW PLC ORD USD0.20 revenue for the last half-year amounts to 2.24 B GBX, despite the estimated figure of 2.23 B GBX. In the next half-year revenue is expected to reach 2.36 B GBX.
SN. net income for the last half-year is 169.20 M GBP, while the previous report showed 72.63 M GBP of net income which accounts for 132.98% change. Track more SMITH & NEPHEW PLC ORD USD0.20 financial stats to get the full picture.
SMITH & NEPHEW PLC ORD USD0.20 dividend yield was 2.82% in 2023, and payout ratio reached 125.07%. The year before the numbers were 2.82% and 150.72% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 25, 2024, the company has 19.55 K employees. See our rating of the largest employees — is SMITH & NEPHEW PLC ORD USD0.20 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SMITH & NEPHEW PLC ORD USD0.20 EBITDA is 1.19 B GBP, and current EBITDA margin is 26.38%. See more stats in SMITH & NEPHEW PLC ORD USD0.20 financial statements.
Like other stocks, SN. shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SMITH & NEPHEW PLC ORD USD0.20 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SMITH & NEPHEW PLC ORD USD0.20 technincal analysis shows the neutral today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SMITH & NEPHEW PLC ORD USD0.20 stock shows the sell signal. See more of SMITH & NEPHEW PLC ORD USD0.20 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.